Page 300 - Williams Hematology ( PDFDrive )
P. 300

274  Part IV:  Molecular and Cellular Hematology  Chapter 18:  Hematopoietic Stem Cells, Progenitors, and Cytokines   275




                    186. O’Farrell AM, Foran JM, Fiedler W, et al: An innovative phase I clinical study dem-    215. Austin TW, Solar GP, Ziegler FC, et al: A role for the Wnt gene family in hematopoiesis:
                     onstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia   Expansion of multilineage progenitor cells. Blood 89:3624, 1997.
                     patients. Clin Cancer Res 9:5465, 2003.              216. Willert K, Brown JD, Danenberg E, et al: Wnt proteins are lipid-modified and can act as
                    187. Lyman SD, James L, Vanden Bos T, et al: Molecular cloning of a ligand for the flt3/flk-2   stem cell growth factors. Nature 423:448, 2003.
                     tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell     217. Reya T, Duncan AW, Ailles L, et al: A role for Wnt signaling in self-renewal of hemato-
                     75:1157, 1993.                                        poietic stem cells. Nature 423:409, 2003.
                    188. Lyman SD, James L, Escobar S, et al: Identification of soluble and membrane-bound iso-    218. Van Den Berg DJ, Sharma AK, Bruno E, Hoffman R: Role of members of the Wnt gene
                     forms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene   family in human hematopoiesis. Blood 92:3189, 1998.
                     10:149, 1995.                                        219. Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the
                    189. Lyman SD, Seaberg M, Hanna R, et al: Plasma/serum levels of flt3 ligand are low in   nucleus. Cell 113:685, 2003.
                     normal individuals and highly elevated in patients with Fanconi anemia and acquired     220. Sitnicka E, Ruscetti FW, Priestley GV, et al: Transforming growth factor beta 1 directly
                     aplastic anemia. Blood 86:4091, 1995.                 and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic
                    190. Mackarehtschian K, Hardin JD, Moore KA, et al: Targeted disruption of the flk2/flt3   stem cells. Blood 88:82, 1996.
                     gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147, 1995.    221. Batard P, Monier MN, Fortunel N, et al: TGF-(beta)1 maintains hematopoietic imma-
                    191. Rasko JE, Metcalf D, Rossner MT, et al: The flt3/flk-2 ligand: Receptor distribution and   turity by a reversible negative control of cell cycle and induces CD34 antigen up-mod-
                     action on murine haemopoietic cell survival and proliferation. Leukemia 9:2058, 1995.  ulation. J Cell Sci 113(Pt 3):383, 2000.
                    192. Robinson S, Mosley RL, Parajuli P, et al: Comparison of the hematopoietic activity of     222. Larsson J, Blank U, Helgadottir H, et al: TGF-beta signaling-deficient hematopoietic
                     flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in   stem cells have normal self-renewal and regenerative ability in vivo despite increased
                     combination. J Hematother Stem Cell Res 9:711, 2000.  proliferative capacity in vitro. Blood 102:3129, 2003.
                    193. Kobayashi M, Laver JH, Kato T, et al: Thrombopoietin supports proliferation of human     223. Larsson J, Karlsson S: The role of Smad signaling in hematopoiesis. Oncogene 29:5676,
                     primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood   2005.
                     88:429, 1996.                                        224. Blank U, Karlsson G, Moody JL, et al: Smad7 promotes self-renewal of hematopoietic
                    194. Piacibello W, Sanavio F, Garetto L, et al: Extensive amplification and self-renewal of   stem cells in vivo. Blood 108:4246, 2006.
                     human primitive hematopoietic stem cells from cord blood. Blood 89:2644, 1997.    225. Karlsson G, Blank U, Moody JL, et al: Smad4 is critical for self-renewal of hematopoi-
                    195. Namikawa R, Muench MO, de Vries JE, et al: The FLK2/FLT3 ligand synergizes with   etic stem cells. J Exp Med 204:467, 2007.
                     interleukin-7 in promoting stromal-cell-independent expansion and differentiation of     226. Lengerke C, Schmitt S, Bowman TV, et al: BMP and Wnt specify hematopoietic fate by
                     human fetal pro-B cells in vitro. Blood 87:1881, 1996.  activation of the Cdx-Hox pathway. Cell Stem Cell 2:72, 2008.
                    196. Strobl H, Bello-Fernandez C, Riedl E, et al: Flt3 ligand in cooperation with transform-    227. Timm A, Grosschedl R: Wnt signaling in lymphopoiesis. Curr Top Microbiol Immunol
                     ing growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic   290:225, 2005.
                     cells and allows single-cell dendritic cell cluster formation under serum-free condi-    228. Ross S, Hill CS: How the Smads regulate transcription. Int J Biochem Cell Biol 40:383,
                     tions. Blood 90:1425, 1997.                           2008.
                    197. Kaushansky K: Thrombopoietin: The primary regulator of platelet production. Blood     229. Krosl G, He G, Lefrancois M, et al: Transcription factor SCL is required for c-kit expres-
                     86:419, 1995.                                         sion and c-Kit function in hemopoietic cells. J Exp Med 188:439, 1998.
                    198. Qian S, Fu F, Li W, et al: Primary role of the liver in thrombopoietin production shown     230. Kirito K, Fox N, Kaushansky K: Thrombopoietin stimulates Hoxb4 expression:
                     by tissue-specific knockout. Blood 92:2189, 1998.     An explanation for the favorable effects of TPO on hematopoietic stem cells. Blood
                    199. Kaushansky K: Thrombopoietin. N Engl J Med 339:746, 1998.  102:3172, 2003.
                    200. Sitnicka E, Lin N, Priestley GV, et al: The effect of thrombopoietin on the proliferation     231. Kirito K, Fox N, Kaushansky K: Thrombopoietin (TPO) induces the nuclear translo-
                     and differentiation of murine hematopoietic stem cells. Blood 87:4998, 1996.  cation of HoxA9 in hematopoietic stem cells (HSC): A potential explanation for the
                    201. Kobayashi M, Laver JH, Kato T, et al: Recombinant human thrombopoietin (Mpl lig-  favorable effects of TPO on HSCs. Mol Cell Biol 24:6751, 2004.
                     and) enhances proliferation of erythroid progenitors. Blood 86:2494, 1995.    232. Tong W, Lodish HF: Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocy-
                    202. Kaushansky K, Broudy VC, Grossmann A, et al: Thrombopoietin expands erythroid   topoiesis. J Exp Med 200:569, 2004.
                     progenitors, increases red cell production, and enhances erythroid recovery after mye-    233. Tong W, Zhang J, Lodish HF: Lnk inhibits erythropoiesis and EPO-dependent JAK2
                     losuppressive therapy. J Clin Invest 96:1683, 1995.   activation and downstream signaling pathways. Blood 105:4604, 2005.
                    203. Akahori H, Shibuya K, Obuchi M, et al: Effect of recombinant human thrombopoietin     234. Takaki S, Sauer K, Iritani BM, et al: Control of B cell production by the adaptor protein
                     in nonhuman primates with chemotherapy-induced thrombocytopenia. Br J Haematol   lnk: Definition of a conserved family of signal-modulating proteins. Immunity 13:599,
                     94:722, 1996.                                         2000.
                    204. Neelis KJ, Hartong SC, Egeland T, et al: The efficacy of single-dose administration of     235. Seita J, Ema H, Ooehara J, et al: Lnk negatively regulates self-renewal of hematopoietic
                     thrombopoietin  with  coadministration  of  either  granulocyte/macrophage  or  granu-  stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad
                     locyte colony-stimulating factor in myelosuppressed rhesus monkeys. Blood 90:2565,   Sci U S A 104:2349, 2007.
                     1997.                                                236. Buza-Vidas N, Antonchuk J, Qian H, et al: Cytokines regulate postnatal hematopoietic
                    205. Farese AM, Hunt P, Grab LB, et al: Combined administration of recombinant human   stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev 20:2018,
                     megakaryocyte growth and development factor and granulocyte colony-stimulating   2006.
                     factor enhances multilineage hematopoietic reconstitution in nonhuman primates after     237. Schick PK, Wojenski CM, Bennett VD, et al: The synthesis and localization of alterna-
                     radiation-induced marrow aplasia. J Clin Invest 97:2145, 1996.  tively spliced fibronectin EIIIB in resting and thrombin-treated megakaryocytes. Blood
                    206. Alexander WS, Roberts AW, Nicola NA, et al: Deficiencies in progenitor cells of mul-  87:1817, 1996.
                     tiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the     238. Prosper F, Stroncek D, McCarthy JB, et al: Mobilization and homing of peripheral blood
                     thrombopoietic receptor c-Mpl. Blood 87:2162, 1996.   progenitors is related to reversible downregulation of alpha4 beta1 integrin expression
                    207. Yagi M, Ritchie KA, Sitnicka E, et al: Sustained ex vivo expansion of hematopoietic stem   and function. J Clin Invest 101:2456, 1998.
                     cells mediated by thrombopoietin. Proc Natl Acad Sci U S A 96:8126, 1999.    239. Dao MA, Hashino K, Kato I, et al: Adhesion to fibronectin maintains regenerative
                    208. Broxmeyer HE, Kohli L, Kim CH, et al: Stromal cell-derived factor-1/CXCL12 directly   capacity during ex vivo culture and transduction of human hematopoietic stem and
                     enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(al-  progenitor cells. Blood 92:4612, 1998.
                     pha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leu-    240. Yokota T, Oritani K, Mitsui H, et al: Growth-supporting activities of fibronectin
                     koc Biol 73:630, 2003.                                on hematopoietic stem/progenitor cells  in vitro and  in vivo: Structural require-
                    209. Lee Y, Gotoh A, Kwon H-J, et al: Enhancement of intracellular signaling associated with   ment for fibronectin activities of CS1 and cell-binding domains.  Blood 91:3263,
                     hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with   1998.
                     other cytokines. Blood 99:4307, 2002.                241. Bhatia R, Williams AD, Munthe HA: Contact with fibronectin enhances preservation
                    210. Ellisen LW, Bird J, West DC, et al: TAN-1, the human homolog of the Drosophila notch   of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors.
                     gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.  Cell   Exp Hematol 30:324, 2002.
                     66(4):649, 1991.                                     242. Liu S, Kiosses WB, Rose DM, et al: A fragment of paxillin binds the alpha 4 integrin
                    211. Milner LA, Kopan R, Martin DI, Bernstein ID: A human homologue of the Drosophila   cytoplasmic domain (tail) and selectively inhibits alpha 4-mediated cell migration.
                     developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. Blood   J Biol Chem 277:20887, 2002.
                     83:2057, 1994.                                       243. Sarkar S, Svoboda M, de Beaumont R, et al: The role of Aktand RAFTK in beta1 inte-
                    212. Karanu FN, Murdoch B, Gallacher L, et al: The notch ligand jagged-1 represents a novel   grin mediated survival of precursor B-acute lymphoblastic leukemia cells. Leuk Lym-
                     growth factor of human hematopoietic stem cells. J Exp Med 192:1365, 2000.  phoma 43:1663, 2002.
                    213. Karanu FN, Murdoch B, Miyabayashi T, et al: Human homologues of Delta-1 and     244. Zhao J, Bian ZC, Yee K, et al: Identification of transcription factor KLF8 as a down-
                     Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood   stream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle pro-
                     97:1960, 2001.                                        gression. Mol Cell 11:1503, 2003.
                    214. Varnum-Finney B, Brashem-Stein C, Bernstein ID: Combined effects of Notch signal-    245. Schlaepfer DD, Hunter T: Focal adhesion kinase overexpression enhances ras-dependent
                     ing and cytokines induce a multiple log increase in precursors with lymphoid and mye-  integrin signaling to ERK2/mitogen-activated protein kinase through interactions with
                     loid reconstituting ability. Blood 101:1784, 2003.    and activation of c-Src. J Biol Chem 272:13189, 1997.







          Kaushansky_chapter 18_p0257-0278.indd   275                                                                   9/19/15   12:06 AM
   295   296   297   298   299   300   301   302   303   304   305